Director, Obesity and Metabolic Diseases

About this role

Job Description

The Director, Obesity and Metabolic Diseases will provide scientific leadership and people management for discovery research in obesity and metabolic diseases within the Cardiometabolic Disease (CMD) Department at our Company's Research Laboratories in South San Francisco, California. The successful candidate will contribute to and execute scientific priorities within the department’s strategy by integrating advances in human biology, translational science, data science, and innovative technology platforms to identify and advance novel therapeutic opportunities. Working in a highly collaborative and multidisciplinary environment, this individual will lead a focused team of scientists, drive discovery programs from target identification through preclinical development, and contribute to a differentiated pipeline of medicines that address the unmet medical needs of patients living with obesity and related metabolic disorders.

Responsibilities: • Lead discovery research in obesity and metabolic diseases, executing priorities aligned with CMD scientific strategy from target identification through preclinical candidate nomination by leveraging human biology, translational science, disease models, and emerging technologies to contribute to a differentiated portfolio. • Provide scientific leadership for drug discovery programs, partnering across chemistry, pharmacology, safety, translational medicine, biomarker, and development functions to inform program priorities, support decision making, and advance programs through key milestones. • Identify and advance novel therapeutic opportunities by integrating insights from human genetics, clinical research, biomarker science, and the external competitive landscape, while maintaining deep expertise in obesity, metabolism, and related therapeutic areas. • Lead a high-performing scientific team by fostering a culture of innovation, scientific rigor, collaboration, accountability, and continuous talent development. • Contribute to the evaluation of external innovation, business development opportunities, and partnership strategies that enhance the portfolio. • Represent the team through publications, presentations, due diligence activities, governance interactions, and cross-functional scientific forums, contributing to the broader cardiometabolic disease strategy.

QUALIFICATIONS:

Education: • Ph.D., M.D., or Ph.D./M.D. in endocrinology, metabolism, physiology, pharmacology, biology or a related scientific discipline and a minimum of eight (8) years of experience in obesity, diabetes, MASH, or related therapeutic areas in academia and/or industry.  Exceptional candidates from academia with a distinguished record of scientific achievement and research leadership are encouraged to apply, even without prior industry experience.

Required Experience and Skills: • Demonstrated track record of scientific innovation, leadership of research programs, and contributions to basic and/or translational research efforts. • Deep expertise in metabolic disease biology and target validation, with a strong understanding of human genetics, biomarkers, and the integration of preclinical and clinical data to inform drug discovery decisions. • Proven success leading scientific teams and discovery initiatives in a matrix environment, with the ability to manage priorities, collaborate across functions, influence stakeholders, and deliver results. • Broad experience with in vitro and in vivo models of obesity and metabolic disease, as well as contemporary therapeutic modalities and innovative technologies relevant to drug discovery. • People leadership experience, including managing, coaching, and developing scientific teams, with a demonstrated ability to build and sustain a high-performing team, foster employee engagement, and develop talent through mentorship, performance management, and succession planning. • Strong communication, collaboration, and relationship-building skills, with the ability to effectively engage leaders, cross-functional partners, and external collaborators.

Required Leadership Competencies: • Demonstrates strategic thinking and scientific judgment, translating complex data into clear decisions that advance program and team objectives. • Builds trust, alignment, and strong partnerships across functions by fostering an inclusive, collaborative, and high-performing culture. • Develops and empowers talent through effective coaching, mentorship, and succession planning, creating an environment where team members can excel. • Operates effectively in a matrix organization, influencing across functions while maintaining a strong focus on execution, innovation, and patient impact. • Demonstrates the highest standards of scientific integrity, ethics, diversity, and accountability, while championing excellence and continuous improvement.

Preferred Experience and Skills: • Experience in pharmacology is highly desired, including the design, execution, and interpretation of in vitro and in vivo studies to support target validation, mechanism-of-action investigations, and therapeutic development.

#EligibleforERP 

Required Skills: Biomarker Research, Diabetes Research, Metabolic Diseases, Metabolism, Obesity Research, People Leadership, Pharmacology, Strategic Leadership, Translational Research Preferred Skills:

Current Employees apply HERE

Current Contingent Workers apply HERE

US and Puerto Rico Residents Only:

Our company is committed to inclusion, ensuring that candidates can engage in a hiring process that exhibits their true capabilities. Please click here if you need an accommodation during the application or hiring process. As an Equal Employment Opportunity Employer, we provide equal opportunities to all employees and applicants for employment and prohibit discrimination on the basis of race, color, age, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability status, or other applic

Similar jobs

• Senior Medical Director, Clinical Development, Obesity — Neurocrine · US CA San Diego
• Director, Clinical Research, Obesity — Merck · Rahway, New Jersey, United States | Boston (MA Parcel B Laboratory), Massachusetts, United States
• Director, GLP-1 and Cardiometabolic Health Program Manager — Omadahealth · Remote
• Associate Medical Director/Medical Director, Endocrinology and Metabolism — Corcepttherapeutics · Redwood City, California, United States
• Director of Communications, Obesity, CVRM — AstraZeneca · MA, Boston
• Director, Epidemiology — CSL · Americas, US-PA, King of Prussia, CSL Behring | Seqirus USA - MA - Waltham
• Assistant Professor of Clinical - Medicine, Gastroenterology, Endobariatric and Obesity — Umfaculty · Doral, FL
• Director, Health Economics and Outcomes Research — Inovalon · Bowie, MD